Global Progress and Challenges in Implementing New Medications for Treating Multidrug-Resistant Tuberculosis

Two new drugs—bedaquiline and delamanid—have recently been approved by stringent regulatory authorities to treat multidrug-resistant tuberculosis (TB) and recommended by the World Health Organization for use under defined programmatic conditions. Introducing the medications in TB programs worldwide...

Descripción completa

Detalles Bibliográficos
Autores principales: Furin, Jennifer, Brigden, Grania, Lessem, Erica, Rich, Michael, Vaughan, Laura, Lynch, Sharonann
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2016
Materias:
Online Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4766879/
https://www.ncbi.nlm.nih.gov/pubmed/26885674
http://dx.doi.org/10.3201/eid2203.151430

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4766879/
https://www.ncbi.nlm.nih.gov/pubmed/26885674
http://dx.doi.org/10.3201/eid2203.151430

Ejemplares similares